Filing Flows › OptimizeRx (OPRX) › Q4 2024
OptimizeRx (OPRX) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 20, 2025
OptimizeRx (OPRX) reported revenue of $32.3M for the fourth quarter 2024 (Q4 2024), +14% from a year earlier and +52% from the quarter before. Operating margin was 11.2%, net loss $78K (0.2% of revenue).
OptimizeRx, Q4 2024: revenue $32.3M (+14% year over year), operating margin 11.2%, net loss $78K, operating cash flow $198K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32.3M | +52% | +14% |
| Operating profit | $3.6M | — | — |
| Net earnings | −$78K | — | — |
| Operating cash flow | $198K | -89% | — |
| Free cash flow | $181K | -90% | — |
What changed
Revenue was $32.3M in Q4 2024, up 14% year over year and up 52% from the previous quarter.
Gross margin was 68.1%, up 5.3 points from a year earlier. Operating profit was $3.6M, a 11.2% margin (up 49.7 points year over year). Operating expenses fell 36% while revenue rose 14%. The quarter ended with a net loss of $78K, narrower than the previous quarter's $9.1M loss. Net interest and other expense of $1.4M was the main reason.
Operating cash flow was $198K. Non-cash charges added back $1.1M of depreciation and amortization and $2.9M of share-based compensation. Working capital and other items used $3.8M. Capital expenditures of $17K left free cash flow of $181K.
Questions
What was OptimizeRx's revenue in the fourth quarter 2024?
OptimizeRx (OPRX) reported revenue of $32.3M for the fourth quarter 2024 (Q4 2024), +14% from a year earlier and +52% from the quarter before.
Was OptimizeRx profitable in the fourth quarter 2024?
Operating profit was $3.6M (11.2% of revenue) and net loss $78K.
Source: OptimizeRx 10-K on SEC EDGAR.